Related Experiment Video

Updated: Jan 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.9K

Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the

Emma Svennberg1, Jose Luis Merino2, Jason Andrade3

  • 1Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|December 15, 2025
PubMed

Insights

Atrial fibrillation (AF) management is evolving towards personalized, multi-domain therapy. Experts recommend combining stroke prevention, rhythm control, and condition treatment for better patient outcomes.

Area of Science:

  • Cardiology
  • Medical Innovation
  • Health Policy

Background:

  • Atrial fibrillation (AF) presents a significant and growing unmet medical need.
  • Current treatments focus on stroke prevention, managing co-existing conditions, and rhythm control.
  • Innovations include new anti-thrombotic agents, anti-arrhythmic drugs (AADs), and interventional therapies.

Purpose of the Study:

  • To outline the emerging consensus on multi-domain therapy for atrial fibrillation.
  • To describe advancements in personalized risk estimation and therapy selection.
  • To highlight the need for integrated approaches in AF management.

Main Methods:

  • Consensus conference involving over 80 experts from academia and industry.
  • Discussion of innovations in stroke prevention, rhythm control, and cardiometabolic therapies.
  • Exploration of quantitative traits for AF phenotyping and risk-driven therapy.

Main Results:

  • Emerging consensus favors multi-domain therapy integrating stroke prevention, rhythm control, and concomitant condition management.
  • Personalized AF risk estimation is replacing simple scores, utilizing quantifiable features.
  • Combination therapies (anticoagulants, AADs, ablation, cardiometabolic drugs) aim to reduce AF risk and complications.

Conclusions:

  • A shift towards risk-driven, personalized therapy based on AF phenotypes is recommended.
  • Data science and AI can enhance risk estimation and therapy selection.
  • Integrated, patient-centered AF management requires ongoing research into reversing AF drivers and improving stroke prevention.

Keywords:
AblationAntiarrhythmic drugsArtificial intelligenceAtrial fibrillationAtrial fibrillation burdenHeart failureIntegrated careRhythm controlStroke prevention

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.7K

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
411
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220